• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

替考霉素A2与万古霉素对葡萄球菌和肠球菌的体外活性比较。

Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.

作者信息

Cynamon M H, Granato P A

出版信息

Antimicrob Agents Chemother. 1982 Mar;21(3):504-5. doi: 10.1128/AAC.21.3.504.

DOI:10.1128/AAC.21.3.504
PMID:6213192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC181923/
Abstract

The in vitro activity of teichomycin A2 was compared with that of vancomycin by standardized agar dilution testing against clinical isolates of staphylococci and enterococci. Both antibiotics had similar activities against staphylococci. However, teichomycin A2 was significantly more active against enterococci.

摘要

通过针对葡萄球菌和肠球菌临床分离株的标准化琼脂稀释试验，比较了替考霉素A2与万古霉素的体外活性。两种抗生素对葡萄球菌的活性相似。然而，替考霉素A2对肠球菌的活性明显更高。

相似文献

1
Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.替考霉素A2与万古霉素对葡萄球菌和肠球菌的体外活性比较。
Antimicrob Agents Chemother. 1982 Mar;21(3):504-5. doi: 10.1128/AAC.21.3.504.
2
Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.替考拉宁与万古霉素单独及联合利福平、氨基糖苷类药物对葡萄球菌和肠球菌的体外比较活性
Antimicrob Agents Chemother. 1984 Apr;25(4):411-2. doi: 10.1128/AAC.25.4.411.
3
In vitro activity of teichomycin against isolates of gram-positive bacteria.
Chemotherapy. 1983;29(4):275-82. doi: 10.1159/000238209.
4
In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.替考霉素A2与青霉素和万古霉素相比对革兰氏阳性球菌的体外活性。
Eur J Clin Microbiol. 1982 Oct;1(5):278-81. doi: 10.1007/BF02019971.
5
Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.多重耐药革兰氏阳性病原体。当前微生物学模式的最新情况。
Drugs. 1997;54 Suppl 6:11-20. doi: 10.2165/00003495-199700546-00005.
6
Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
Diagn Microbiol Infect Dis. 1991 Jan-Feb;14(1):29-31. doi: 10.1016/0732-8893(91)90084-s.
7
A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.葡萄球菌和链球菌对替考拉宁和万古霉素反应的比较。
J Antimicrob Chemother. 1987 Aug;20(2):155-64. doi: 10.1093/jac/20.2.155.
8
[The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].替考拉宁和万古霉素对革兰氏阳性微生物的体外活性（校正后）
Mikrobiyol Bul. 1991 Oct;25(4):321-5.
9
In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.替考拉宁和万古霉素单独及与利福平联合使用时的体外活性。
Antimicrob Agents Chemother. 1983 Mar;23(3):402-6. doi: 10.1128/AAC.23.3.402.
10
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.研究性糖肽类抗生素LY333328对肠球菌和葡萄球菌的体外活性。
Antimicrob Agents Chemother. 1996 Oct;40(10):2416-9. doi: 10.1128/AAC.40.10.2416.

引用本文的文献

1
Update on Coagulase-Negative Staphylococci-What the Clinician Should Know.凝固酶阴性葡萄球菌的最新情况——临床医生应了解的内容。
Microorganisms. 2021 Apr 14;9(4):830. doi: 10.3390/microorganisms9040830.
2
Old and New Glycopeptide Antibiotics: Action and Resistance.新旧糖肽类抗生素：作用与耐药性。
Antibiotics (Basel). 2014 Nov 4;3(4):572-94. doi: 10.3390/antibiotics3040572.
3
Comparative activity of daptomycin and teicoplanin against enterococci isolated from blood and urine.达托霉素和替考拉宁对从血液和尿液中分离出的肠球菌的比较活性。
Can J Infect Dis. 1992 Jul;3(4):173-8. doi: 10.1155/1992/257026.
4
Population pharmacokinetics of teicoplanin in patients with endocarditis.
J Pharmacokinet Biopharm. 1995 Feb;23(1):25-39. doi: 10.1007/BF02353784.
5
Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis.门诊静脉注射替考拉宁治疗慢性骨髓炎的经验。
Eur J Clin Microbiol Infect Dis. 1995 Jul;14(7):643-7. doi: 10.1007/BF01690746.
6
In vitro activity and human pharmacokinetics of teicoplanin.替考拉宁的体外活性及人体药代动力学
Antimicrob Agents Chemother. 1984 Dec;26(6):881-6. doi: 10.1128/AAC.26.6.881.
7
The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin against Streptococcus faecalis.万古霉素和替考拉宁单独及与庆大霉素或氨苄西林联合应用对粪肠球菌的活性。
Eur J Clin Microbiol. 1984 Oct;3(5):436-8. doi: 10.1007/BF02017366.
8
Pharmacokinetics of teicoplanin in man after intravenous administration.替考拉宁静脉给药后的人体药代动力学。
J Pharmacokinet Biopharm. 1984 Apr;12(2):119-28. doi: 10.1007/BF01059273.
9
Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.替考拉宁与万古霉素单独及联合利福平、氨基糖苷类药物对葡萄球菌和肠球菌的体外比较活性
Antimicrob Agents Chemother. 1984 Apr;25(4):411-2. doi: 10.1128/AAC.25.4.411.
10
In vitro activity of teicoplanin and vancomycin against anaerobes.替考拉宁和万古霉素对厌氧菌的体外活性。
Eur J Clin Microbiol. 1984 Feb;3(1):50-1. doi: 10.1007/BF02032822.

本文引用的文献

1
Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.替考霉素，来自新放线菌（新种）的新型抗生素。I. 产生菌的描述、发酵研究及生物学特性
J Antibiot (Tokyo). 1978 Apr;31(4):276-83. doi: 10.7164/antibiotics.31.276.
2
Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization.替考霉素，来自新种替考游动放线菌的新型抗生素。II. 提取与化学特性分析。
J Antibiot (Tokyo). 1978 Mar;31(3):170-7. doi: 10.7164/antibiotics.31.170.